How Neil Woodford beat all other UK equity income funds

Neil Woodford deserves will be throwing a party after the table topping success of his flagship fund CF Woodford Equity Income, says Harvey Jones.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Neil Woodford has had his critics lately, but now he deserves a slap on the back and hearty birthday congratulations. The dividend hero has been running his flagship CF Woodford Equity fund for three years, and has once again confirmed his stellar reputation.

Happy third birthday

I have been sent figures by fund platform Chelsea Financial Services showing that Neil Woodford is top of the UK equity income tree over three years. Incredibly, he is first out of 79 funds in the sector, delivering growth of 38.79% over the period, against an average return of 25.81%. Worst performer, Allianz UK Equity income, grew just 16.13%, less than half his return.

Our favourite star fund manager has done it again. That’s despite slipping in the past 12 months, when he returned 14.2%, against a sector average of 18.2% and his other vehicle Patient Capital Trust stalled. His reputation is such that the haters are waiting to pounce. So why has CF Woodford Equity Income done so well? Helpfully, in the spirit of transparency, he publishes his full portfolio holdings and one thing quickly becomes clear: Woodford is his own man.

Lonely are the brave

In most equity income funds, the same names feature again and again, notably oil majors BP and Royal Dutch Shell, HSBC Holdings and Lloyds Banking Group, pharmaceuticals AstraZeneca and GlaxoSmithKline, and tobacco stocks British American Tobacco and Imperial Brands Group. Most managers like to play it safe. Invest in those and you won’t be too far off the benchmark, and will keep your job. Woodford doesn’t play that game.

Only four of these companies feature among the 131 stocks in his portfolio: AstraZeneca in first place, Imperial Brands (2), British American Tobacco (5) and Lloyds (11). Woodford has snubbed plenty of other big names: BP, Diageo, GlaxoSmithKline, Shell, Unilever and Vodafone Group may number among the 10 largest stocks on the FTSE 100 but do not merit a place in his fund. Brave man.

No hugs

Woodford’s top 10 holdings include plenty of lesser names, with medical and pharmaceuticals firms Abbvie, ProthenaTheravance Biopharma and the unquoted Benevolent AI all prominent in the top 10. Woodford is no closet benchmark hugger.

Not every stock pick has paid off, for example, top 10 holding Capita is down 50% over the past 12 months. Prothena is up only 6% over three years, Legal & General is up just 9%. However, others have done better, Abbvie is up 30% over three years, Imperial Brands, Theravance Biopharma and Provident Financial are all up 37% and British American Tobacco is up 53%.

You win again

However, the real excitement comes lower down, with the lesser names providing a number of growth heroes including PurpleBricks, up 211% in the last 12 months, Stobart Group is up 116% in a year, and best of all Burford Capital, up 187% over one year and 677% over three.

As you might expect from a portfolio with 131 stocks in it, Woodford has also backed some losers, sluggards and no-shows, he has just backed fewer of them than other managers, and more of the good guys. The performance chart does not lie. Woodford is still a winner.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones holds units in CF Woodford Equity income but has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended AstraZeneca, BP, Diageo, Imperial Brands, Lloyds Banking Group, and Royal Dutch Shell B. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »